Neurovascular Devices/Interventional Neurology Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Neurovascular Devices/Interventional Neurology Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032



Growth Factors Of Neurovascular Devices Market

The neurovascular devices market size was valued at USD 3.15 billion in 2022, and the market is now projected to grow from USD 3.43 billion in 2023 to USD 6.51 billion by 2030, exhibiting a CAGR of 9.6% during the forecast period of 2023-2030.

The COVID-19 pandemic created significant opportunities on the neurovascular devices market growth as curbing coronavirus outbreak was prioritized. The market saw slow development because of transitory closure of neurovascular centers and the higher focal point of medical care suppliers toward Coronavirus patients. In addition, decline in the quantity of visits to neurovascular facilities and production network disturbances affected the deals of neurovascular gadgets.

The neurovascular devices market share globally has been contributed due to the Rising Frequency of Neurovascular Conditions. The rising pervasiveness of neurovascular conditions like stroke, cerebral aneurysms, and others is one of the huge variables adding to the rising patient populace worldwide. The pervasiveness of these neurovascular conditions is higher in the geriatric populace.

Furthermore, there’s been a notable trend of Rising Automation Progressions. Different players have been continually putting resources into Research and development to zero in on underpenetrated areas of neurovascular mediations and present new items on the lookout. The improvement of new embolic loops, yearning catheters in view of trend setting innovations, and revascularization gadgets for ischemic strokes are a portion of the main instances’ areas of strength for of toward cutting-edge neurovascular gadgets.

Comprehensive Neurovascular Devices Market

Neurovascular gadgets incorporate stenting frameworks, embolization gadgets, and neurothrombectomy gadgets for treating neurovascular issues like mind aneurysms. The rising pervasiveness of these issues among the populace and rising government drives to make mindfulness with respect to treatment choices are supposed to fuel the item interest to deal with these sicknesses.

North America represented the most elevated neurovascular gadgets market share and created an income of USD 1.35 billion of every 2022. The district is expected to overwhelm the market before long inferable from the developing pervasiveness of different neurological problems and higher finding and treatment rates. In addition, developing medical services consumption supporting neurological consideration in the district and satisfactory repayment for different neurological issues will advance the reception of cutting edge, novel therapy choices in the area.

The top players in the market play a crucial role in the neurovascular devices market assuring industrial prospectus growth and setting market standards. These players include, Medtronic (U.S.), Penumbra, Inc. (U.S.), Stryker (U.S.), Johnson and Johnson Services, Inc. (CERENOVUS) (U.S.), MicroPort Scientific Corporation (China) these market players provide a level-playing competitive landscape.

In October 2022, Medtronic declared the sendoff of Neurovascular Co-Lab Platform intended to speed up direly required advancement in stroke care and treatment.

Segmentation Table

Neurovascular Devices Market Scope

Study Period 2019-2032

Base Year 2023

Forecast Period 2023-2030

Growth Rate CAGR of 9.6% from 2023-2030

Historical Period 2019-2022

Unit Value (USD Billion)

Segmentation By Type, End-User, and Region

By Type Stenting Systems

Embolization Devices

Neurothrombectomy Devices

Support Devices

By End-User

Cerebral Aneurysms

Ischemic Stroke

Others

By Region North America (By Type, End-User, and Country)

- U.S. (By Type and End-User)

- Canada (By Type and End-User)

Europe (By Type, End-User, and Country/Sub-region)

- U.K. (By Type and End-User)

- Germany (By Type and End-User)

- France (By Type and End-User)

- Italy (By Type and End-User)

- Spain (By Type and End-User)

- Rest of Europe (By Type and End-User)

Asia Pacific (By Type, End-User, and Country/Sub-region)

- China (By Type and End-User)

- Japan (By Type and End-User)

- India (By Type and End-User)

- Australia (By Type and End-User)

- Rest of Asia Pacific (By Type and End-User)

Latin America (By Type, End-User, and Country/Sub-region)

- Brazil (By Type and End-User)

- Mexico (By Type and End-User)

- Rest of Latin America (By Type and End-User)

Middle East & Africa (By Type, End-User, and Country/ Sub-region)

- GCC (By Type and End-User)

- South Africa (By Type and End-User)

- Rest of Middle East & Africa (By Type and End-User)


Please Note: It will take 5-6 business days to complete the report upon order confirmation.


1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends
4. Key Insights
4.1. Incidence of Stroke, By Key Countries, 2022
4.2. New Product Launches, Key Market Players
4.3. Technological Advancements in Neurovascular Devices
4.4. Key Industry Developments (Mergers, Acquisitions, etc.)
4.5. Impact of COVID-19 on the Neurovascular Devices Market
5. Global Neurovascular Devices Market Analysis, Insights and Forecast, 2019-2030
5.1. Market Analysis, Insights and Forecast – By Device Type
5.1.1. Stenting Systems
5.1.2. Embolization Devices
5.1.3. Neuothrombectomy Devices
5.1.4. Support Devices
5.2. Market Analysis, Insights and Forecast – By Application
5.2.1. Cerebral Aneurysms
5.2.2. Ischemic Stroke
5.2.3. Others
5.3. Market Analysis, Insights and Forecast – By End-user
5.3.1. Hospitals
5.3.2. Specialty Clinics
5.3.3. Others
5.4. Market Analysis, Insights and Forecast – By Region
5.4.1. North America
5.4.2. Europe
5.4.3. Asia Pacific
5.4.4. Latin America
5.4.5. Middle East & Africa
6. North America Neurovascular Devices Market Analysis, Insights and Forecast, 2019-2030
6.1. Market Analysis, Insights and Forecast – By Device Type
6.1.1. Stenting Systems
6.1.2. Embolization Devices
6.1.3. Neuothrombectomy Devices
6.1.4. Support Devices
6.2. Market Analysis, Insights and Forecast – By Application
6.2.1. Cerebral Aneurysms
6.2.2. Ischemic Stroke
6.2.3. Others
6.3. Market Analysis, Insights and Forecast – By End-user
6.3.1. Hospitals
6.3.2. Specialty Clinics
6.3.3. Others
6.4. Market Analysis, Insights and Forecast – By Country
6.4.1. U.S.
6.4.2. Canada
7. Europe Neurovascular Devices Market Analysis, Insights and Forecast, 2019-2030
7.1. Market Analysis, Insights and Forecast – By Device Type
7.1.1. Stenting Systems
7.1.2. Embolization Devices
7.1.3. Neuothrombectomy Devices
7.1.4. Support Devices
7.2. Market Analysis, Insights and Forecast – By Application
7.2.1. Cerebral Aneurysms
7.2.2. Ischemic Stroke
7.2.3. Others
7.3. Market Analysis, Insights and Forecast – By End-user
7.3.1. Hospitals
7.3.2. Specialty Clinics
7.3.3. Others
7.4. Market Analysis, Insights and Forecast – By Country/Sub-region
7.4.1. Germany
7.4.2. U.K.
7.4.3. France
7.4.4. Italy
7.4.5. Spain
7.4.6. Scandinavia
7.4.7. Rest of Europe
8. Asia Pacific Neurovascular Devices Market Analysis, Insights and Forecast, 2019-2030
8.1. Market Analysis, Insights and Forecast – By Device Type
8.1.1. Stenting Systems
8.1.2. Embolization Devices
8.1.3. Neuothrombectomy Devices
8.1.4. Support Devices
8.2. Market Analysis, Insights and Forecast – By Application
8.2.1. Cerebral Aneurysms
8.2.2. Ischemic Stroke
8.2.3. Others
8.3. Market Analysis, Insights and Forecast – By End-user
8.3.1. Hospitals
8.3.2. Specialty Clinics
8.3.3. Others
8.4. Market Analysis, Insights and Forecast – By Country/Sub-region
8.4.1. China
8.4.2. India
8.4.3. Japan
8.4.4. Australia
8.4.5. Southeast Asia
8.4.6. Rest of Asia Pacific
9. Latin America Neurovascular Devices Market Analysis, Insights and Forecast, 2019-2030
9.1. Market Analysis, Insights and Forecast – By Device Type
9.1.1. Stenting Systems
9.1.2. Embolization Devices
9.1.3. Neuothrombectomy Devices
9.1.4. Support Devices
9.2. Market Analysis, Insights and Forecast – By Application
9.2.1. Cerebral Aneurysms
9.2.2. Ischemic Stroke
9.2.3. Others
9.3. Market Analysis, Insights and Forecast – By End-user
9.3.1. Hospitals
9.3.2. Specialty Clinics
9.3.3. Others
9.4. Market Analysis, Insights and Forecast – By Country/Sub-region
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
10. Middle East & Africa Neurovascular Devices Market Analysis, Insights and Forecast, 2019-2030
10.1. Market Analysis, Insights and Forecast – By Device Type
10.1.1. Stenting Systems
10.1.2. Embolization Devices
10.1.3. Neuothrombectomy Devices
10.1.4. Support Devices
10.2. Market Analysis, Insights and Forecast – By Application
10.2.1. Cerebral Aneurysms
10.2.2. Ischemic Stroke
10.2.3. Others
10.3. Market Analysis, Insights and Forecast – By End-user
10.3.1. Hospitals
10.3.2. Specialty Clinics
10.3.3. Others
10.4. Market Analysis, Insights and Forecast – By Country/Sub-region
10.4.1. South Africa
10.4.2. GCC
10.4.3. Rest of Middle East & Africa
11. Competitive Analysis
11.1. Global Market Share Analysis (2022)
11.2. Company Profiles (Overview, Product, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
11.2.1. Medtronic
11.2.1.1. Overview,
11.2.1.2. Product,
11.2.1.3. SWOT Analysis,
11.2.1.4. Recent Developments,
11.2.1.5. Strategies,
11.2.1.6. financials (Based on Availability)
11.2.2. Penumbra, Inc.
11.2.2.1. Overview,
11.2.2.2. Product,
11.2.2.3. SWOT Analysis,
11.2.2.4. Recent Developments,
11.2.2.5. Strategies,
11.2.2.6. financials (Based on Availability)
11.2.3. Stryker
11.2.3.1. Overview,
11.2.3.2. Product,
11.2.3.3. SWOT Analysis,
11.2.3.4. Recent Developments,
11.2.3.5. Strategies,
11.2.3.6. financials (Based on Availability)
11.2.4. Johnson and Johnson Services Inc. (CERENOVUS)
11.2.4.1. Overview,
11.2.4.2. Product,
11.2.4.3. SWOT Analysis,
11.2.4.4. Recent Developments,
11.2.4.5. Strategies,
11.2.4.6. financials (Based on Availability)
11.2.5. MicroPort Scientific Corporation
11.2.5.1. Overview,
11.2.5.2. Product,
11.2.5.3. SWOT Analysis,
11.2.5.4. Recent Developments,
11.2.5.5. Strategies,
11.2.5.6. financials (Based on Availability)
11.2.6. Acandis GmbH
11.2.6.1. Overview,
11.2.6.2. Product,
11.2.6.3. SWOT Analysis,
11.2.6.4. Recent Developments,
11.2.6.5. Strategies,
11.2.6.6. financials (Based on Availability)
11.2.7. MicroVention Inc.
11.2.7.1. Overview,
11.2.7.2. Product,
11.2.7.3. SWOT Analysis,
11.2.7.4. Recent Developments,
11.2.7.5. Strategies,
11.2.7.6. financials (Based on Availability)
11.2.8. NeuroVasc Technologies, Inc.
11.2.8.1. Overview,
11.2.8.2. Product,
11.2.8.3. SWOT Analysis,
11.2.8.4. Recent Developments,
11.2.8.5. Strategies,
11.2.8.6. financials (Based on Availability)
11.2.9. Asahi Intecc USA, Inc.
11.2.9.1. Overview,
11.2.9.2. Product,
11.2.9.3. SWOT Analysis,
11.2.9.4. Recent Developments,
11.2.9.5. Strategies,
11.2.9.6. financials (Based on Availability)
11.2.10. Perflow Medical Ltd.
11.2.10.1. Overview,
11.2.10.2. Product,
11.2.10.3. SWOT Analysis,
11.2.10.4. Recent Developments,
11.2.10.5. Strategies,
11.2.10.6. financials (Based on Availability)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings